Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to predict who will develop multiple myeloma

NCT ID NCT07214324

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 33 times

Summary

This study looks at 60 people with early blood conditions (MGUS or SMM) that can sometimes turn into multiple myeloma, a type of blood cancer. Researchers will use advanced genetic and immune testing to find clues that predict progression. The goal is to better identify high-risk individuals and guide future prevention efforts.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Istituto Ortopedico Rizzoli IRCCS

    ACTIVE_NOT_RECRUITING

    Bologna, Italy

  • S.C Ematologia - Azienda USL IRCCS di Reggio Emilia

    RECRUITING

    Reggio Emilia, Italy

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco"

    ACTIVE_NOT_RECRUITING

    Catania, Italy

  • UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone"

    ACTIVE_NOT_RECRUITING

    Palermo, Italy

Conditions

Explore the condition pages connected to this study.